Strategies for Approaching Frontline Therapy in EGFR+ NSCLC

preview_player
Показать описание
Experts explain why to use targeted therapy over immunotherapy for patients with driver mutations in NSCLC and the importance of molecular testing before choosing a therapy.
  1. OncLive
  2. cancer
  3. oncology
Рекомендации по теме
Strategies for Approaching 0:08:00

Strategies for Approaching Frontline Therapy in EGFR+ NSCLC

The frontline treatment 0:05:11

The frontline treatment strategy for newly diagnosed AML

Approaching Frontline Therapy 0:02:11

Approaching Frontline Therapy Options for Ovarian Cancer

Frontline Therapy for 0:08:42

Frontline Therapy for mCRC

Can A+AVD replace 0:01:25

Can A+AVD replace PET-directed strategies for the frontline treatment of Hodgkin lymphoma?

Frontline Therapy Approaches 0:04:37

Frontline Therapy Approaches for Small Cell Lung Cancer

Approaches to Second-Line 0:03:13

Approaches to Second-Line Therapy in mRCC

Maintenance and Frontline 0:05:26

Maintenance and Frontline Therapy in CLL

Selecting the Optimal 0:04:20

Selecting the Optimal Frontline Therapy in CLL

The current frontline 0:04:51

The current frontline treatment strategy in multiple myeloma

Frontline Caregiver Strategies 0:06:50

Frontline Caregiver Strategies for Patients Approaching Life's Final Transition

Targeting ALK - 0:45:52

Targeting ALK - From Discovery to Frontline Treatment

Frontline Treatment Approaches 0:08:56

Frontline Treatment Approaches in Advanced RCC

Emerging immunotherapeutic strategies 0:02:26

Emerging immunotherapeutic strategies for multiple myeloma in the frontline and R/R settings

Frontline treatment strategies 0:01:59

Frontline treatment strategies in AML

Unanswered questions in 0:00:57

Unanswered questions in frontline CLL treatment

Fixed-duration treatment strategies 0:00:56

Fixed-duration treatment strategies for frontline and relapsed CLL

Optimizing Frontline Therapy 0:05:41

Optimizing Frontline Therapy and Maintenance in FL

Frontline Therapy Approach 0:04:52

Frontline Therapy Approach for Stage 4 GEJ Cancer

The optimum approach 0:02:51

The optimum approach to frontline treatment of CLL in 2021

Dr. Hari on 0:01:35

Dr. Hari on Current State of Frontline Therapy in Myeloma

Sequencing Strategies in 0:04:08

Sequencing Strategies in Frontline CLL

CLL14: feasibility of 0:01:32

CLL14: feasibility of fixed-duration frontline therapy in CLL

Frontline Therapy Options 0:06:28

Frontline Therapy Options for Multiple Myeloma